162 related articles for article (PubMed ID: 29773301)
21. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.
Rahangdale L; Sarnquist C; Yavari A; Blumenthal P; Israelski D
J Womens Health (Larchmt); 2010 Apr; 19(4):709-12. PubMed ID: 20201703
[TBL] [Abstract][Full Text] [Related]
22. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
23. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
24. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
Linder J; Zahniser D
Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
[TBL] [Abstract][Full Text] [Related]
25. Effects of gel lubricant on cervical cytology.
Charoenkwan K; Ninunanahaeminda K; Khunamornpong S; Srisomboon J; Thorner PS
Acta Cytol; 2008; 52(6):654-8. PubMed ID: 19068667
[TBL] [Abstract][Full Text] [Related]
26. HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.
Richardson LA; El-Zein M; Ramanakumar AV; Ratnam S; Sangwa-Lugoma G; Longatto-Filho A; Cardoso MA; Coutlée F; Franco EL;
Cancer Cytopathol; 2015 Dec; 123(12):745-54. PubMed ID: 26230283
[TBL] [Abstract][Full Text] [Related]
27. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
28. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
Budge M; Halford J; Haran M; Mein J; Wright G
Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
[TBL] [Abstract][Full Text] [Related]
29. The Value of Papanicolaou Tests in the Diagnosis of Endometrial Carcinoma: A Large Study Cohort From an Academic Medical Center.
Serdy K; Yildiz-Aktas I; Li Z; Zhao C
Am J Clin Pathol; 2016 Mar; 145(3):350-4. PubMed ID: 27124917
[TBL] [Abstract][Full Text] [Related]
30. Preinvasive and Invasive Cervical Adenocarcinoma: Preceding Low-Risk or Negative Pap Result Increases Time to Diagnosis.
Moukarzel LA; Angarita AM; VandenBussche C; Rositch A; Thompson CB; Fader AN; Levinson K
J Low Genit Tract Dis; 2017 Apr; 21(2):91-96. PubMed ID: 27977543
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
[TBL] [Abstract][Full Text] [Related]
32. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
33. ThinPrep Pap Test. Accuracy for glandular disease.
Ashfaq R; Gibbons D; Vela C; Saboorian MH; Iliya F
Acta Cytol; 1999; 43(1):81-5. PubMed ID: 9987455
[TBL] [Abstract][Full Text] [Related]
34. Automated quantitative fluorescent image analysis of cervical cytology.
Smith JJ; Cowan L; Hemstreet G; Smith ML; Pippitt CH; Doggett R; McGill L
Gynecol Oncol; 1987 Nov; 28(3):241-54. PubMed ID: 3678975
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
[TBL] [Abstract][Full Text] [Related]
36. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
Eltabbakh GH; Eltabbakh GD
J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.
Zhao L; Wentzensen N; Zhang RR; Dunn ST; Gold MA; Wang SS; Schiffman M; Walker JL; Zuna RE
Cancer Cytopathol; 2014 Sep; 122(9):694-701. PubMed ID: 24888458
[TBL] [Abstract][Full Text] [Related]
38. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
[TBL] [Abstract][Full Text] [Related]
39. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
40. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
Chacho MS; Mattie ME; Schwartz PE
Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
